LEVOTHYROXINE SODIUM
| Brand name | LEVOTHYROXINE SODIUM |
|---|---|
| Active ingredient | LEVOTHYROXINE SODIUM |
| Strength | 100MCG/ML |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | May 2021 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11154498 | July 2036 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.